FibromaxFibrosis, Activity, STEATO, ASH and NASH of Liver in Akola

Patients date of birth, Height, Weight is must. Fasting Required

Fibromax is a test that is used to assess the risk of fibrosis (or scarring) in the liver. Fibrosis is a common complication of chronic liver disease, and it can lead to cirrhosis and liver failure. The test is a non-invasive method that measures the levels of specific biomarkers in the blood, which can indicate the presence and severity of liver fibrosis. These biomarkers are produced by the liver when it is damaged and attempts to repair itself.

The Fibromax test assesses the fibrosis activity by evaluating biochemicals like SGPT, SGOT, Triglycerides, Cholesterol, FBS, Bilirubin, Alpha 2 macroglobulin, Haptoglobulin, Apo A1, GGT and determines the cause of fibrosis. It can distinguish between steatohepatitis – alcoholic or nonalcoholic.

Alcoholic steatohepatitis (ASH) is a type of liver disease that occurs in people who drink excessive amounts of alcohol. The liver becomes inflamed and filled with fat, leading to liver damage and scarring (cirrhosis).

Nonalcoholic steatohepatitis (NASH) is a type of liver disease that occurs in people who do not drink excessive amounts of alcohol. Instead, it is characterized by the buildup of fat in the liver (steatosis), along with inflammation and liver cell damage. This can lead to cirrhosis. It is more common in individuals with risk factors such as obesity, metabolic syndrome, diabetes, and high triglycerides levels.

Written by : Supriya Kulkarni, Lead-Content & Training